Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elena Fradkov, M.D.

Concepts (62)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiodysplasia12017220.550 Why?
Nursing Staff120171130.530 Why?
Cannabinoids120191740.530 Why?
Skin Diseases1202210880.430 Why?
Gastroenterology120175940.360 Why?
Colitis1201912390.340 Why?
Gastrointestinal Hemorrhage1201711270.330 Why?
Crohn Disease1202222830.330 Why?
Endoscopy1201718410.280 Why?
Heart-Assist Devices1201712960.260 Why?
Ventricular Function, Left1201739280.230 Why?
Students, Medical1201719590.230 Why?
Leukocyte L1 Antigen Complex12022920.190 Why?
Interleukin-23120222020.180 Why?
Endoscopy, Gastrointestinal120228880.130 Why?
Vomiting120196470.120 Why?
Platelet Aggregation Inhibitors2201727700.120 Why?
Heart Failure12017118400.100 Why?
Syndrome1201932710.100 Why?
Anticoagulants2201748620.090 Why?
Blood Coagulation1201711660.090 Why?
History, 21st Century1201715740.090 Why?
Guidelines as Topic1201713940.090 Why?
Skin Diseases, Vesiculobullous12011840.090 Why?
C-Reactive Protein1202238500.090 Why?
Prosthesis Design1201721050.090 Why?
Teaching1201711690.080 Why?
History, 20th Century1201727610.080 Why?
Warfarin1201714940.080 Why?
Receptor, Adenosine A2B12008330.080 Why?
Receptor, Adenosine A2A120081270.070 Why?
Fibrinolytic Agents1201720800.070 Why?
Guideline Adherence1201722430.070 Why?
Recovery of Function1201729660.070 Why?
Aspirin1201731340.060 Why?
Case-Control Studies12022222230.060 Why?
Treatment Outcome22022651880.050 Why?
Inflammation12022108500.050 Why?
Quality Improvement1201738530.050 Why?
Killer Cells, Natural1201122100.050 Why?
Clinical Competence1201748630.050 Why?
T-Lymphocytes, Cytotoxic1200818010.050 Why?
Immune Tolerance1200823240.040 Why?
Autoimmune Diseases1201122260.040 Why?
Risk Assessment12017242820.030 Why?
Humans520227659680.030 Why?
Retrospective Studies12022815140.030 Why?
Pemphigus120111070.020 Why?
Risk Factors12017748400.020 Why?
Adenosine-5'-(N-ethylcarboxamide)12008150.020 Why?
Adenosine A2 Receptor Agonists12008310.020 Why?
Mice, Inbred DBA120086230.020 Why?
Animals220171687640.020 Why?
Extracellular Space120085630.020 Why?
Cytotoxicity, Immunologic1200813470.010 Why?
Cyclic AMP1200814670.010 Why?
Adenosine120088060.010 Why?
Interferon-gamma1200831600.010 Why?
Lymphocyte Activation1200855010.010 Why?
Cell Line, Tumor12008170750.010 Why?
Mice, Inbred C57BL12008223320.010 Why?
Mice12008818190.000 Why?
Fradkov's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (62)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.